Profluent uses machine learning models to author new proteins and gene editors from scratch for therapeutics and industrial applications.
What it is
Profluent is a biotechnology company utilizing machine learning to author entirely new proteins and gene editors for medical and industrial use. By combining biological research with advanced computation, the system creates customized molecular structures that serve as the foundation for modern medicines and novel biological treatments.
Key features
- AI-driven protein generation capable of creating novel molecular structures from scratch.
- OpenCRISPR, an AI-designed gene editor demonstrating direct authorship in action.
- Custom therapeutic development created through strategic pharmaceutical partnerships.
- Specialized machine learning models trained on biological scaffolds and natural patterns.
- Industrial enzyme design targeted at complex manufacturing and agricultural challenges.
Who it's for
Profluent is built for pharmaceutical companies, biotechnology researchers, and life science organizations seeking to incorporate machine learning into their drug discovery and gene editing pipelines.
Pricing
Check the official website for current pricing and partnership details.
Use cases
- Design novel proteins
- Generate custom gene editors
- Create new therapeutics
- Develop industrial enzymes
Categories:
Similar to Profluent
More Profluent alternatives
Leash Bio
OtherMachine learning for drug design and chemical screening
Leash Bio builds massive protein-molecule datasets and trains machine learning models to design new medicinal compounds and accelerate drug discovery.
